🇺🇸 FDA
Patent

US 10799512

Estrogen combination for treatment of multiple sclerosis

granted A61KA61K31/565A61K31/566

Quick answer

US patent 10799512 (Estrogen combination for treatment of multiple sclerosis) held by The Regents of the University of California expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/565, A61K31/566, A61K31/567, A61K31/57